Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. Open Access Indonesian Journal of Medical Reviews, v. 6, n. 1, p. 1–20, 13 Nov.2025.